The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $702,204 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the London School of Hygiene and Tropical Medicine (LSHTM) to conduct research on complex malaria in India. The key products and services to be delivered through this 5-year project include: Monitoring the changing epidemiology of malaria in Odisha, India through a 4-year community-based cohort study to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,211,704 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Emory University. The grant, awarded on September 10, 2024, will support comprehensive studies in India to elucidate the pathogenesis of severe dengue disease during primary infections and how it differs from secondary infections. The research aims to: 1) Determine differences in innate immune responses during severe...
This $133,664 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to characterize the network of vector-host-virus interactions within wetland ecosystems in Argentina. The key objectives are to: Identify host bloodmeals in wetland mosquitoes to elucidate the potential viral flow between resident and migratory birds. Analyze the previous exposure of migratory and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) provides $433,303.00 to the Trustees of Indiana University, doing business as Indiana University Indianapolis, to develop an eco-friendly soda-based attractive targeted sugar bait (ATSB) system for delivering RNA interference (RNAi)-based mosquito insecticides. The goal is to create a universally attractive mosquito lure that selectively kills mosquitoes,...
This Project Grant award of $699,339, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 "Allergy and Infectious Diseases Research", will support a 5-year research project to study the transmission dynamics of dengue and Zika viruses in northwestern coastal Ecuador. The research team, led by the University of Michigan, will conduct parallel longitudinal studies of human and mosquito populations across diverse communities to characterize how...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $240,300.00 to the Regents of the University of Michigan to develop brain-penetrating bispecific antibodies (BABs) for delivering neutralizing antibodies against Eastern Equine Encephalitis Virus (EEEV) to the brain. The objectives are to evaluate the brain uptake, toxicity, and therapeutic effectiveness of...
This Project Grant award from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI) CFDA 10.310 program provides $194,318.00 to the University of California, Santa Barbara to investigate how agricultural intensification affects mosquito abundance, viral infection rates, and farmworker exposure to mosquito-borne diseases. The research aims to improve the well-being and health of farmworkers, a...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $648,924 to Iowa State University of Science and Technology to conduct research on the role of mosquito extracellular vesicles in malaria parasite killing and immune priming. The 5-year project, running from February 2025 to January 2030, aims to obtain a mechanistic understanding of how extracellular vesicles...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $360,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Virginia Polytechnic Institute & State University (Virginia Tech) to develop a gerbil model to delineate the mechanism of Hepatitis E Virus (HEV) extrahepatic pathogenesis. The key objectives are to: 1) Determine the effect of HEV-3-induced pyroptosis in neurovascular unit (NVU) cells and identify the mechanisms of...
This Project Grant award for $174,544, awarded by the National Science Foundation (NSF) under the Computer and Information Science and Engineering (CFDA 47.070) program, supports the development of a novel, integrated geospatial framework that applies advanced machine learning techniques to map disease-transmission risk for mosquito-borne infectious diseases in Southern Africa. The key products and services to be delivered under this award include: High-resolution satellite imagery processed...